Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

Researchers found a relationship between the genetics of tumors with germline BRCA1/2 mutations and whether the tumor retains the normal copy of the BRCA1/2 gene, and risk for primary resistance to a common chemotherapy that works by destroying cancer cells’ DNA.

This post was syndicated from Top Health News -- ScienceDaily. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply